| Cell death independent of caspases: a review LE Broker, FAE Kruyt, G Giaccone Clinical Cancer Research 11 (9), 3155-3162, 2005 | 1334 | 2005 |
| Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA JR Lo Ten Foe, MA Rooimans, L Bosnoyan-Collins, N Alon, M Wijker, ... Nature genetics 14 (3), 320-323, 1996 | 521 | 1996 |
| Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with … ML Janmaat, FAE Kruyt, JA Rodriguez, G Giaccone Clinical Cancer Research 9 (6), 2316-2326, 2003 | 412 | 2003 |
| Apoptosis: target of cancer therapy CG Ferreira, M Epping, FAE Kruyt, G Giaccone Clinical Cancer Research 8 (7), 2024-2034, 2002 | 403 | 2002 |
| Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α–ZEB1 axis JV Joseph, S Conroy, K Pavlov, P Sontakke, T Tomar, E Eggens-Meijer, ... Cancer letters 359 (1), 107-116, 2015 | 355 | 2015 |
| Global histone modifications predict prognosis of resected non–small-cell lung cancer F Barlési, G Giaccone, MI Gallegos-Ruiz, A Loundou, SW Span, ... Journal of clinical oncology 25 (28), 4358-4364, 2007 | 332 | 2007 |
| Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells LE Bröker, C Huisman, SW Span, JA Rodriguez, FAE Kruyt, G Giaccone Cancer research 64 (1), 27-30, 2004 | 292 | 2004 |
| Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor TJN Hiltermann, MM Pore, A van den Berg, W Timens, HM Boezen, ... Annals of oncology 23 (11), 2937-2942, 2012 | 285 | 2012 |
| Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460 CG Ferreira, SW Span, GJ Peters, FAE Kruyt, G Giaccone Cancer research 60 (24), 7133-7141, 2000 | 269 | 2000 |
| CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin JA Rodríguez, SW Span, CGM Ferreira, FAE Kruyt, G Giaccone Experimental cell research 275 (1), 44-53, 2002 | 260 | 2002 |
| Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer B Pennarun, A Meijer, EGE de Vries, JH Kleibeuker, F Kruyt, S de Jong Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (2), 123-140, 2010 | 252 | 2010 |
| The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG JP De Winter, L Van Der Weel, J De Groot, S Stone, Q Waisfisz, F Arwert, ... Human Molecular Genetics 9 (18), 2665-2674, 2000 | 252 | 2000 |
| TRAIL and cancer therapy FAE Kruyt Cancer letters 263 (1), 14-25, 2008 | 242 | 2008 |
| Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family K Azijli, B Weyhenmeyer, GJ Peters, S De Jong, FAE Kruyt Cell Death & Differentiation 20 (7), 858-868, 2013 | 234 | 2013 |
| TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion JV Joseph, S Conroy, T Tomar, E Eggens-Meijer, K Bhat, S Copray, ... Cell death & disease 5 (10), e1443-e1443, 2014 | 209 | 2014 |
| TGF-β as a therapeutic target in high grade gliomas–promises and challenges JV Joseph, V Balasubramaniyan, A Walenkamp, FAE Kruyt Biochemical pharmacology 85 (4), 478-485, 2013 | 198 | 2013 |
| Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase FAE Kruyt, T Hoshino, JM Liu, P Joseph, AK Jaiswal, H Youssoufian Blood, The Journal of the American Society of Hematology 92 (9), 3050-3056, 1998 | 187 | 1998 |
| A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA Q Waisfisz, JP De Winter, FAE Kruyt, J De Groot, L Van Der Weel, ... Proceedings of the National Academy of Sciences 96 (18), 10320-10325, 1999 | 176 | 1999 |
| Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients CG Ferreira, P van der Valk, SW Span, I Ludwig, EF Smit, FAE Kruyt, ... Clinical cancer research 7 (8), 2468-2474, 2001 | 175 | 2001 |
| Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cells ML Janmaat, JA Rodriguez, M Gallegos‐Ruiz, FAE Kruyt, G Giaccone International journal of cancer 118 (1), 209-214, 2006 | 174 | 2006 |
Steven de JongProfessor of Preclinical and Translational Oncology, University Medical Center GroningenVahvistettu sähköpostiosoite verkkotunnuksessa umcg.nl
